Introduction Despite the clinical implementation, there remain significant gaps in our knowledge regarding the impact of race/ethnicity or common medical comorbidity on plasma Alzheimer's disease (AD) biomarkers. Methods Plasma biomarkers of amyloid beta (Aβ) 40, Aβ 42 , total tau, and neurofilam…